BioForce Announces Award From State of Iowa
News Oct 03, 2005
BioForce Nanosciences, Inc. has announced that the State of Iowa Department of Economic Development has approved an award to the company from the Community Economic Betterment Account (CEBA).
BioForce was awarded $500,000 to support commercialization of its award-winning NanoArrayer™ technology for production of ultraminiaturized biomedical tests and devices.
The Company Founder and CEO, Dr. Eric Henderson, said, “The Company's unique NanoArrayer System gives scientists a new and fundamental tool to enable further advances in nanotechnology.”
“You have to have a ball bearing before you can build an automobile, and you have to have a NanoArrayer before you can build a nanobot.”
These funds will allow BioForce to create high value employment opportunities, and retain existing jobs at their facilities in Ames.
Ames comes close to defining what State leaders tout as Iowa's “new economy” with emerging growth companies, stable government employers, and strong manufacturing companies.
“This type of State support helps in our efforts to keep pace with the explosive growth of nanotechnology elsewhere in the USA and abroad,” says Henderson.
Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of BloodNews
A team of international researchers led by Professor Martin Hegner, Investigator in CRANN and Trinity’s School of Physics, have developed an automated diagnostic platform that can quantify bleeding – and thrombotic risks – in a single drop of blood, within seconds.READ MORE
Targeting Headaches and Tumors with Nano-SubmarinesNews
Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.READ MORE
Magnetized Wire Could be used to Detect Cancer in PeopleNews
Scientists at Stanford used the wire to capture free-floating tumor cells in the blood, a technique that soon could be used in humans to yield an earlier cancer diagnosis.READ MORE